Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Best Defense Is Good Offense: PhRMA Wants PBMs To 'Share The Savings'

Executive Summary

PhRMA ad campaign targets US payer practice of using drug rebate dollars for general premium and cost sharing reductions and not to lower the cost of specific prescription fills.

You may also be interested in...



UnitedHealthcare Will Share The Savings: Point-Of-Sale Rebates Coming In 2019

Biggest benefit to manufacturers from the insurer's upcoming program may be relieving public pressure on list prices.

The Rebate Debate: Forbes Panelists On How Rebates Trickle Down To Patients

Express Scripts CEO Timothy Wentworth and PhRMA President Steven Ubl discussed some of the issues around drug rebating practices at the Forbes Healthcare Summit, including point-of-sale rebates.

Point-Of-Sale Rebates In Part D: Study Highlights Trade-Offs For Medicare

Analysis funded by Pharmaceutical Care Management Association concludes that using drug rebates to lower beneficiary cost sharing at the point-of-sale would raise premiums and increase government spending.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel